HealthEquity (HQY) Tops Q2 EPS by 16c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
Go back to HealthEquity (HQY) Tops Q2 EPS by 16c; offers guidance
September 4, 2024 12:49 PM EDT
Deutsche Bank analyst George Hill raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $103.00 (from $102.00) while maintaining a Buy rating.
The analyst comments "Solid Q2 Beat On Broad-based Strength: HQY reported another strong quarter with F2Q total revenue of $299.9 million coming in... More
September 4, 2024 5:24 AM EDT
BofA Securities analyst Allen Lutz lowered the price target on HealthEquity, Inc (NASDAQ: HQY) to $100.00 (from $105.00) while maintaining a Buy rating.
The analyst comments "Our Buy thesis for HealthEquity is predicated on faster than market organic growth, supplemented by portfolio M&A, and further enhanced by operating leverage. To date, the biggest driver of... More
September 4, 2024 5:10 AM EDT
BTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 while maintaining a Buy rating.
The analyst comments "On Tuesday, 9/3/24 AMC, HQY reported excellent F2Q:25 results. Total revenue of $299.9M +23% y/y exceeded BTIG / consensus estimates of... More
